Click to read the Excipient quality blog post.
Click to read the Excipient quality blog post.
previous next

Can changes to prescription labels and other public standards help tame the opioid crisis?

The opioid crisis in the U.S. seems to be part of nearly every news broadcast and news site today. And based on the number of people affected by this crisis, serious conversations about how to help are more important than ever. The CDC estimates that more than 100 Americans die every day from an opioid overdose. And nearly 12 million people – close to 4% of the U.S.

Share

Generic drugs: New approaches to maximize competition, lower prices and increase access

Generic drugs

Building the marketplace for generic medicines is a key strategy to containing drug costs in the US, one that USP actively supports through our standards-setting work.

Tags: Generics
Share

Convening Experts to Examine the Critical Underpinnings of Antimicrobial Resistance Strategies

Scenarios of a post-antibiotic society are dire and include massive, highly preventable loss of life, widening socio-economic disparities, and significant economic shortfalls. Estimates of the potential economic impact of antimicrobial resistance (AMR) could be as large as a global annual GDP shortfall of nearly $3.4 trillion by 2030 and $7 trillion by 2050.[i] Currently, 700,000 people die every year due to drug-resistant infections globally.[ii]

Share

Pages

Related Stories

Increasing the sources of quality medicines in LMICs: Challenges and strategies
Increasing the sources of quality medicines in LMICs: Challenges and strategies
USP Excipient Monographs & Standards
USP Excipient Monographs & Standards
Characterization of Biologics: USP Standards
Medicine Quality Assurance: USP's Technical Review Program